ARTICLE | Clinical News
NovoSeven regulatory update
April 10, 2006 7:00 AM UTC
NVO withdrew an application from EMEA to extend the indication for NovoSeven after the CHMP requested additional safety and efficacy data. NVO was seeking to extend the application to include the trea...